Laurel Oak Wealth Management »

SPDR S&P Biotech shares owned by Laurel Oak Wealth Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Laurel Oak Wealth Management from 13F filings

Historical chart of Laurel Oak Wealth Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Laurel Oak Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Laurel Oak Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $207k 1.3k 158.25

More positions owned by Laurel Oak Wealth Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Vanguard Index Fds Growth Etf (VUG)
Listed Fds Tr Swan Hedged Eqty (HEGD)
JPMorgan Chase & Co. (JPM)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Spdr Series Trust St Str P500val (SPYV)
Vanguard Specialized Funds Div App Etf (VIG)
Innovator Etfs Trust Defined Wlt Shld (BALT)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Laurel Oak Wealth Management

Top funds holding SPDR S&P Biotech

Bnp Paribas Arbitrage, Snc
Goldman Sachs Group
Morgan Stanley
Citigroup
Bank of America Corporation
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Citadel Advisors
Wells Fargo & Company
UBS Group
Peak6
Barclays
Millennium Management
Leucadia National Corporation

View all funds holding SPDR S&P Biotech